Join Europe’s Trusted
Health Data Network

On 3 December, Dries will be joining the panel on the "European Health Data Space (EHDS): collaboration and partnerships for successful implementation" at Health Tech Forward in Barcelona.

Meet us at ESMO AI & Digital Oncology 2025, where we will be presenting our poster and be giving a mini oral presentation!

Meet us at ISPOR Europe 2025 this November as we join the global conversation on real-world evidence and health economics. Book a meeting now!

We'll be at ESMO 2025 in Berlin! Don't miss out on our poster: "Comprehensive characterization of evolving immune checkpoint inhibitor (ICI) indications and outcomes through automated standardization of multicenter EHR data"

We are thrilled to announce our participation as a Gold Sponsor at the 2025 OHDSI Europe Symposium, taking place from July 5-7. This year, the symposium makes its debut outside its usual Rotterdam setting, in the historic "Old Prison" building of Hasselt University, Belgium. We look forward engaging with fellow health tech innovators, hospitals, and life sciences organizations to shape the future of health data science.

On 26 March, at the European Lung Cancer Congress, Dr. Decoster (UZ Brussels) will be presenting the joint poster "Real-World Biomarker Testing and Treatment Patterns in Belgian Lung Cancer Patients: Insights from the AIBED Study".

On January 31st, at the BSMO 2025 Congress, Dr. Nuytemans (AZ Groeninge) unveiled the insights from a Belgian multi-center real-world study in breast cancer patients.

We will be attending ISPOR Europe 2024 in Barcelona. Meet our dream team at booth 1126, and discover real-world data use cases in oncology, cardiology and psychiatry, learn more about our European hospital data network and explore the potential of our state-of-the-art proprietary NLP pipeline.

We are attending the 10th annual OHDSI Global symposium.

We will be attending the OHDSI UK symposium in London!

Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.

Meet us at OHDSI Europe 2024 workshops and symposium! On 3 June, Dr. Annelies Verbiest (UZA) and Clara L. Oeste (LynxCare) will provide insights into our Belgian oncology research network and present the initial results from a study into Lung Cancer patients treated with immune checkpoint inhibitors (ICI).